Real World Study of a Adalimumab Biosimilar (Geleli) in Rheumatoid Arthritis
Condition:   Rheumatoid Arthritis Intervention:   Drug: Geleli Sponsor:   Peking University People's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2022 Category: Research Source Type: clinical trials